Orphan medicinal products


Cases suffering from rare diseases earn the same quality of medication as other cases. Given the small number of cases affected by rare conditions, the pharmaceutical assiduity has been reticent in the history to invest in the disquisition and development of medicinal products to treat them and Orphan medicinal products are intended for the opinion, forestalment or treatment of life- hanging or veritably serious conditions that affect no further than 5 in 10,000 people.

Orphan medicinal products:

    Related Conference of Orphan medicinal products

    July 15-16, 2024

    38th International Conference on Immunology

    Toronto, Canada

    Orphan medicinal products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in